Literature DB >> 15470377

Accelerating drug discovery.

Sandra Kraljevic1, Peter J Stambrook, Kresimir Pavelic.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15470377      PMCID： PMC1299137          DOI： 10.1038/sj.embor.7400236

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  31 in total

Review 1.  Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data-rich landscape.

Authors:  S Michelson; K Joho
Journal:  Curr Opin Mol Ther       Date:  2000-12

Review 2.  Proteomics: new perspectives, new biomedical opportunities.

Authors:  R E Banks; M J Dunn; D F Hochstrasser; J C Sanchez; W Blackstock; D J Pappin; P J Selby
Journal:  Lancet       Date:  2000-11-18       Impact factor: 79.321

3.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  Microarray technology: an array of opportunities.

Authors:  Diane Gershon
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

5.  Pharmacogenetics in the laboratory and the clinic.

Authors:  David B Goldstein
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

6.  Comprehensive survey of combinatorial library synthesis: 2001.

Authors:  Roland E Dolle
Journal:  J Comb Chem       Date:  2002 Sep-Oct

Review 7.  The many roles of computation in drug discovery.

Authors:  William L Jorgensen
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

8.  Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles.

Authors:  J F Waring; R A Jolly; R Ciurlionis; P Y Lum; J T Praestgaard; D C Morfitt; B Buratto; C Roberts; E Schadt; R G Ulrich
Journal:  Toxicol Appl Pharmacol       Date:  2001-08-15       Impact factor: 4.219

Review 9.  Pharmacogenomics: the inherited basis for interindividual differences in drug response.

Authors:  W E Evans; J A Johnson
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

10.  The utility of DNA microarrays for characterizing genotoxicity.

Authors:  Ronald K Newton; Marilyn Aardema; Jiri Aubrecht
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031
View more
  27 in total

1.  Development and validation of a modular, extensible docking program: DOCK 5.

Authors:  Demetri T Moustakas; P Therese Lang; Scott Pegg; Eric Pettersen; Irwin D Kuntz; Natasja Brooijmans; Robert C Rizzo
Journal:  J Comput Aided Mol Des       Date:  2006-12-06       Impact factor: 3.686

2.  Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.

Authors:  Sandra Kraljevic; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

3.  Towards preventive medicine. High-throughput methods from molecular biology are about to change daily clinical practice.

Authors:  Hrvojka Bosnjak; Kresimir Pavelic; Sandra Kraljevic Pavelic
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

Review 4.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

5.  Deficiencies in the reporting of VD and t(1/2) in the FDA approved chemotherapy drug inserts.

Authors:  Malcolm J D'Souza; Ghada J Alabed
Journal:  Pharm Rev       Date:  2010-02-03

6.  Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation.

Authors:  S Jagtap; K Meganathan; J Gaspar; V Wagh; J Winkler; J Hescheler; A Sachinidis
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 7.  Approaches to in vitro tissue regeneration with application for human disease modeling and drug development.

Authors:  Mohammad R Ebrahimkhani; Carissa L Young; Douglas A Lauffenburger; Linda G Griffith; Jeffrey T Borenstein
Journal:  Drug Discov Today       Date:  2014-05-02       Impact factor: 7.851

8.  Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.

Authors:  Vaibhav Shinde; Stefanie Klima; Perumal Srinivasan Sureshkumar; Kesavan Meganathan; Smita Jagtap; Eugen Rempel; Jörg Rahnenführer; Jan Georg Hengstler; Tanja Waldmann; Jürgen Hescheler; Marcel Leist; Agapios Sachinidis
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.355

Review 9.  Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Authors:  Yonghe Li; Pui-Kai Li; Michael J Roberts; Rebecca C Arend; Rajeev S Samant; Donald J Buchsbaum
Journal:  Cancer Lett       Date:  2014-04-13       Impact factor: 8.679

10.  Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells.

Authors:  Kesavan Meganathan; Smita Jagtap; Vilas Wagh; Johannes Winkler; John Antonydas Gaspar; Diana Hildebrand; Maria Trusch; Karola Lehmann; Jürgen Hescheler; Hartmut Schlüter; Agapios Sachinidis
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.